Cognitive performance in relapsing remitting multiple sclerosis: A longitudinal study in daily practice using a brief computerized cognitive battery

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Edgar, Chris ^a   Jongen, Peter J ^b   Sanders, Evert ^c   Sindic, Christian ^d   Goffette, Sophie ^d   Dupuis, Michel ^e   Jacquerye, Philippe ^e   Guillaume, Daniel ^f   Reznik, Regine ^f   Wesnes, Keith ^a  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b MS4 Research Institute   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e Clinique Saint Pierre of Ottignies   (Belgium)

^f Centre Neurologique et de Readaptation Fonctionnelle   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COGNITIVE DRUG RESEARCH BATTERY; COMPARATIVE STUDY; COMPUTERIZED COGNITIVE TEST SYSTEM; CONTROLLED STUDY; DIGIT SYMBOL SUBSTITUTION TEST; EPISODIC MEMORY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MEASUREMENT; MENTAL TASK; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS FUNCTIONAL COMPOSITE SCALE; NEUROPSYCHOLOGICAL TEST; PACED AUDITORY SERIAL ADDITION TEST; PSYCHOMETRY; QUALITATIVE ANALYSIS; RECALL; RESPONSE TIME; SCORING SYSTEM; TEST RETEST RELIABILITY; VISUAL INFORMATION; WORKING MEMORY; ADOLESCENT; AGED; AUDITORY STIMULATION; COMPUTER ASSISTED DIAGNOSIS; DISABILITY; HOSPITALIZATION; MEMORY; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; QUALITY OF LIFE; REPRODUCIBILITY; STATISTICS; TIME;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; AGED; COGNITION DISORDERS; DIAGNOSIS, COMPUTER-ASSISTED; DISABILITY EVALUATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TIME FACTORS; YOUNG ADULT;

EID: 79957966680     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-68     Document Type: Article

References (36)

1. Patti F. Cognitive impairment in multiple sclerosis. Mult Scler 2009, 15:2-8. 10.1177/1352458508096684, 18805842.
2. Strober L, Englert J, Munschauer F, Weinstock-Guttman B, Rao S, Benedict RH. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 2009, 15:1077-1084. 10.1177/1352458509106615, 19556311.
3. Amato MP, Zipoli V, Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev Neurother 2008, 8:1585-1596. 10.1586/14737175.8.10.1585, 18928350.
4. Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009, 15:779-788. 10.1177/1352458509105544, 19542262.
5. Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009, 66:1144-1150. 10.1001/archneurol.2009.174, 19752305.
6. Roosendaal SD, Moraal B, Pouwels PJ, Vrenken H, Castelijns JA, Barkhof F, Geurts JJ. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009, 15:708-714. 10.1177/1352458509102907, 19435749.
7. Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 2004, 14:36S-45S.
8. Sanchez MP, Nieto A, Barroso J, Martin V, Hernandez MA. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis. Eur J Neurol 2008, 15:1091-1099. 10.1111/j.1468-1331.2008.02259.x, 18727673.
9. Calabrese M, Rinaldi F, Grossi P, Gallo P. Cortical pathology and cognitive impairment in multiple sclerosis. Expert Rev Neurother 11:425-432.
10. Calabrese P. Neuropsychology of multiple sclerosis--an overview. J Neurol 2006, 253(Suppl 1):I10-15.
11. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008, 7:1139-1151. 10.1016/S1474-4422(08)70259-X, 19007738.
12. Deloire M, Ruet A, Hamel D, Bonnet M, Brochet B. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler 16:581-587.
13. Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 2009, 73:498-503. 10.1212/WNL.0b013e3181b351fd, 19641173.
14. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991, 41:685-691.
15. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991, 41:692-696.
16. Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, Chelune GJ, Fisk JD, Langdon DW, Caruso L, Foley F, LaRocca NG, Vowels L, Weinstein A, DeLuca J, Rao SM, Munschauer F. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002, 16:381-397.
17. Simpson PM, Surmon DJ, Wesnes KA, Wilcock GR. The cognitive drug research computerised assessment system for demented subjects: A validation study. International Journal of Geriatric Psychiatry 1991, 6:95-102.
18. Keith MS, Stanislav SW, Wesnes KA. Validity of a cognitive computerized assessment system in brain-injured patients. Brain Inj 1998, 12:1037-1043. 10.1080/026990598121945, 9876863.
19. Frey PW, Colliver JA. Sensitivity and responsivity measures for discrimination learning. Learning and Motivation 1973, 4:327-342.
20. Jongen PJ, Sindic C, Carton H, Zwanikken C, Lemmens W, Borm G. Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a. J Neurol 257:584-589.
21. Wechsler D. Wechsler Memory Scale Revised Manual 1987, San Antonio TX: Psychological Corp.
22. Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977, 44:367-373.
23. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl) 2000, 152:353-361.
24. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999, 122(Pt 5):871-882.
25. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
26. Wesnes KA, McKeith I, Edgar C, Emre M, Lane R. Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 2005, 65:1654-1656. 10.1212/01.wnl.0000184517.69816.e9, 16301500.
27. Wesnes KA, Edgar C, Dean AD, Wroe SJ. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy Behav 2009, 14:522-528. 10.1016/j.yebeh.2008.11.012, 19111629.
28. Wesnes KA, Edgar C, Tretter RN, Bolodeoku J. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg. Expert Opin Drug Saf 2009,
29. Forn C, Belenguer A, Parcet-Ibars MA, Avila C. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT). J Clin Exp Neuropsychol 2008, 30:789-796. 10.1080/13803390701779560, 18608672.
30. Drake AS, Weinstock-Guttman B, Morrow SA, Hojnacki D, Munschauer FE, Benedict RH. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 16:228-237.
31. Forn C, Belenguer A, Belloch V, Sanjuan A, Parcet MA, Avila C. Anatomical and functional differences between the Paced Auditory Serial Addition Test and the Symbol Digit Modalities Test. J Clin Exp Neuropsychol 1-9.
32. Hanly JG, Omisade A, Su L, Farewell V, Fisk JD. Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests. Arthritis Rheum 62:1478-1486.
33. Beatty WW, Wilbanks SL, Blanco CR, Hames KA, Tivis R, Paul RH. Memory disturbance in multiple sclerosis: reconsideration of patterns of performance on the selective reminding test. J Clin Exp Neuropsychol 1996, 18:56-62. 10.1080/01688639608408262, 8926297.
34. Bever CT, Grattan L, Panitch HS, Johnson KP. The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study. Mult Scler 1995, 1:165-169.
35. Beglinger LJ, Gaydos B, Tangphao-Daniels O, Duff K, Kareken DA, Crawford J, Fastenau PS, Siemers ER. Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol 2005, 20:517-529. 10.1016/j.acn.2004.12.003, 15896564.
36. Wesnes K, Pincock C. Practice effects on cognitive tasks: a major problem?. Lancet Neurol 2002, 1:473. 10.1016/S1474-4422(02)00236-3, 12849328.